Completion and Carryover Summary

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

COMPLETION AND CARRYOVER REPORT for GENERIC ICR 0920-1282

Initial period of approval for generic ICR 0920-1282:  June 2023 – June 2026. 
Requested period of approval for Revision ICR:  June 2026 – June 2029 (estimated).
This report provides a summary of GENICs that were approved in the 2023-2026 timeframe and provides burden and response estimates for continuing these data collections after approval of the Renewal ICR.

UTILIZATION OF THE 0920-1282 GENERIC DURING THE INITIAL PERIOD OF APPROVAL (June 2023 – June 2026)
Generic ICR No. 0920-1282 was approved for 291,147 burden hours over 3 years. Sixteen GENICs were approved and 5 from the Revision ICR June 2023 - June 2026. The burden used during the June 2023 – June 2026 cycle was 148,047 burden hours. 


INFORMATION COLLECTION HAS BEEN COMPLETED FOR THE FOLLOWING GENICs
    • [CSTLTS] Performance Measures to Address COVID-19-Related Health Disparities in Support of the Implementation of the OT21-2103 COVID-19 Health Disparities Grant (carryover to 2023-2025)
    • [GHCU] CDC Global COVID-19: Monitoring and Evaluation of Partners Supporting CDC's International Response to the Coronavirus Pandemic [carryover for 2023-2025)
    • 
CONTINUATION OF PREVIOUSLY APPROVED COLLECTIONS 
At CDC/ATSDR, grants and cooperative agreements are usually funded for multiple years, thus, there is a need to continue performance monitoring for previously approved GENICs in the next approval period for the generic ICR. 
The tables below show how CDC calculated burden and response estimates for carryover GENICs and the impact of these projects on the total burden and response estimates for the Revision ICR.

CDC Center, Institute, or Office (CIO)
Title
Changes
Annualized Burden Hours
Additional Years of Collection
Total Burden Hours Requested, 2026-2029
NCEH
[NCEH] Building Resilience Against Climate Effects: Implementing and Evaluating Adaptation Strategies that Protect and Promote Human Health (carryover to 2023-2025)
None
585
2026, 2027,2028
1,755 
NCHHSTP
[NCHHSTP] Centers for Disease Control and Prevention Ending the HIV Epidemic in the United States: Performance Measures (carryover to 2023-2025)
None
2,660
2026, 2027,2028
7,980
NCHHSTP
[NCHHSTP_OPPE] Performance Measurement for STD PCHD (2026-2028)
None
1,770
2026, 2027, 2028
5,310
NCHHSTP
[NCHHSTP_OPPE] Support and Scale-Up of HIV Prevention Services in Sexual Health Clinics (or SHIPS) Performance Measures
None
57
2026, 2027, 2028
171
NCSTLTPHIW
[OADPS / NCSTLTPHIW] Performance Measures for Strengthening U.S. Public Health Infrastructure, Workforce, and Data Systems Grant OE22-2203 (2023-2025)
None
14,338
2026, 2027, 2028
43,014
NCHHSTP
[OADPS NCHHSTP] Enhancing STI and Sexual Health Clinic Infrastructure
None
2,392
2026, 2027, 2028
7,176
NCEZID
[OADPS/NCEZID] HAI/IR Programs (2023-2025)
None
965
2026, 2027, 2028
2,895
NCCDPHP
[OADPS] [PMP] A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.
None
616
2026, 2027, 2028
1,848
NCHSTLTPHIW
[OADPS] DIS Workforce Supplement - Performance Measures Project
None
885
2026, 2027, 2028
2,655
NCIPC
[OADPS] OD2A-LOCAL Cooperative Agreement (# CD23-0003)
None
1,400
2026, 2027, 2028
4,200
NCEZID
[OADPS] Performance Measures Reporting for Epidemiology and Laboratory Capacity (ELC) Cooperative Agreement
None
2,048
2026, 2027, 2028
6,144
NCIPC
[OADPS] Performance Measures Reporting for OD2A in States Cooperative Agreement
None
1,750
2026, 2027, 2028
5,250
NCHSTLTPHIW
[OPPE] TARGETED EVALUATION PROJECTS (TEPs)-SUPPLEMENT to Performance Measures for Strengthening U.S. Public Health Infrastructure, Workforce, and Data Systems Grant OE22-2203 [2023, 2024]
None
214
2026, 2027, 2028
642
NCEZID
[OPPE] The Global Antimicrobial Resistance (AR) Laboratory and Response Network (Global AR Lab and Response Network) [2024-2026] NCEZID GARLRN
None
80
2026, 2027, 2028
240
ORR
[ORR_PPEO] Performance Measure Specifications and Implementation Guidance: Codebook for Data Entry and Reporting
None
3,168
2026, 2027
6,336
NCCDPHP
NCCDPHP - Performance Measures for the Improving Adolescent Health and Well-Being
None
1,971
2026, 2027
3,942

TOTAL BURDEN HOURS ALLOCATED TO CONTINUE PREVIOUSLY APPROVED GENICs
34,949

99,558

CDC Center, Institute, or Office (CIO)
Title
Changes
Annualized Responses
Additional Years of Collection
Total Responses Requested, 2026-2029
NCEH
[NCEH] Building Resilience Against Climate Effects: Implementing and Evaluating Adaptation Strategies that Protect and Promote Human Health (carryover to 2023-2025)
None
39
3
117
NCHHSTP
[NCHHSTP] Centers for Disease Control and Prevention Ending the HIV Epidemic in the United States: Performance Measures (carryover to 2023-2025)
None
122
3
366
NCHHSTP
[NCHHSTP_OPPE] Performance Measurement for STD PCHD (2026-2028)
None
59
3
177
NCHHSTP
[NCHHSTP_OPPE] Support and Scale-Up of HIV Prevention Services in Sexual Health Clinics (or SHIPS) Performance Measures
None
75
3
225
NCSTLTPHIW
[OADPS / NCSTLTPHIW] Performance Measures for Strengthening U.S. Public Health Infrastructure, Workforce, and Data Systems Grant OE22-2203 (2023-2025)
None
963
3
2,889
NCHHSTP
[OADPS NCHHSTP] Enhancing STI and Sexual Health Clinic Infrastructure
None
104
3
312
NCEZID
[OADPS/NCEZID] HAI/IR Programs (2023-2025)
None
672
3
2,016
NCCDPHP
[OADPS] [PMP] A Strategic Approach to Advancing Health Equity for Priority Populations with or at Risk for Diabetes.
None
77
3
231
NCHSTLTPHIW
[OADPS] DIS Workforce Supplement - Performance Measures Project
None
59
3
177
NCIPC
[OADPS] OD2A-LOCAL Cooperative Agreement (# CD23-0003)
None
80
3
240
NCEZID
[OADPS] Performance Measures Reporting for Epidemiology and Laboratory Capacity (ELC) Cooperative Agreement
None
563
3
1,689
NCIPC
[OADPS] Performance Measures Reporting for OD2A in States Cooperative Agreement
None
100
3
300
NCHSTLTPHIW
[OPPE] TARGETED EVALUATION PROJECTS (TEPs)-SUPPLEMENT to Performance Measures for Strengthening U.S. Public Health Infrastructure, Workforce, and Data Systems Grant OE22-2203 [2023, 2024]
None
107
3
321
NCEZID
[OPPE] The Global Antimicrobial Resistance (AR) Laboratory and Response Network (Global AR Lab and Response Network) [2024-2026] NCEZID GARLRN
None
80
3
240
ORR
[ORR_PPEO] Performance Measure Specifications and Implementation Guidance: Codebook for Data Entry and Reporting
None
62
2
124
NCCDPHP
NCCDPHP - Performance Measures for the Improving Adolescent Health and Well-Being
None
61
2
122

TOTAL BURDEN HOURS ALLOCATED TO CONTINUE PREVIOUSLY APPROVED GENICs
3,236

9,546

New GENICs
CDC estimates that up to 40 CDC funded programs will be phased in over the next three-year project period. Programs may fund activities through a grant, cooperative agreement, or contract. There will be an approximate average of 35 awards (recipients) per program, and up to 875 recipients (also called awardees or respondents) across all participating programs (40 awardees x 35 awards per awardee = 875 recipients). The estimated burden per response is 40 hours. For purposes of burden estimation, CDC estimates semi-annual reporting (twice per year), although some programs may specify annual reporting (once per year).  The estimated annualized number of responses is 1,750 (875 respondents x 2) and the estimated annualized burden is 70,000 hours (1,750 responses x 40 hours per response).
 
The annualized request for new GENICs is 1,750 responses and 70,000 burden hours. 
 
 
New GENICs (2026 – 2029):  Annualized Burden Estimates
Type of Respondents
Form Name
Number of Responses
Average burden per response (in hours)
Total burden (in hours)
CDC/ATSDR Award Recipients (new)
Performance Measures Project Information Collection Tool 
1,750
40
70,000
 
 
Over 3 years, the total capacity requested for new GENICs is 5,280 responses (1,750 x 3) and 210,000 burden hours (70,000 x 3).
 
New GENICs (2026 – 2029):  Total Burden Estimates over 3-Year Period
Type of Respondents
Form Name
Number of responses
Average burden per response (in hours)
Total burden (in hours)
CDC/ATSDR Award Recipients (new)
Performance Measures Project Information Collection Tool 
5,250
40
210,000
 
 
SUMMARY OF ANNUALIZED AND 3-YEAR TOTALS:  BURDEN HOURS AND RESPONSES, June 2026-June 2029(EST)

SUMMARY OF ANNUALIZED RESPONSES REQUESTED, June 2026 – June 2029
Project Category (new or previously approved)
Responses Requested (annualized)
Responses Requested (3-year total)
New GENICs
1,750
5,250
Continuation of previously approved GENICs
3,236
9,708
Total
4,986
14,958



SUMMARY OF ANNUALIZED BURDEN HOURS REQUESTED, June 2026 – June 2029
Continuation burden is derived from an average of 10.8 hrs per response (3,236 annual responses)
Project Category (new or previously approved)
Burden Hours Requested
(annualized)
Burden Hours Requested (3-year total)
New GENICs
70,000
210,000
Continuation of previously approved GENICs
34,949
104,847
Total
104,949
314,847